Clinical trials
Hemorrhage trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Australian and New Zealand Intensive Care Research Centre | 2 |
| Ethicon, Inc. | 2 |
| Gold Coast Hospital and Health Service | 2 |
| Idorsia Pharmaceuticals Ltd. | 2 |
| Pfizer | 2 |
| Sangart | 2 |
| Takeda | 2 |
| Abbott Medical Devices | 1 |
| Anne Murray | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 30 |
| Stroke | 5 |
| Purpura, Thrombocytopenic, Idiopathic | 4 |
| Wounds and Injuries | 4 |
| Autoimmune Diseases | 3 |
| Blood Platelet Disorders | 3 |
| Hematologic Diseases | 3 |
| Hemorrhagic Disorders | 3 |
| Immune System Diseases | 3 |
| Purpura | 3 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.